Profound Medical Corp chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.31
Dividend & YieldN/A$ (N/A)
Beta 1.81
Market capitalization 96.94M
Operating cash flow -24.23M
ESG Scores unknown

Company description

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Sector: Healthcare - Industry: Medical Devices

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -957.05k 98k 281k -356k
Total Cashflows From Investing Activities -189k -189k -350k -593k
Net Borrowings 12.33M -1.25M -9.61M -386k
Total Cash From Financing Activities 37.88M 6.6M 87.43M 5.95M
Change To Operating Activities 461.03k -1.74M 1.25M -13k
Issuance Of Stock 34.61M 8.71M 103.68M 6.43M
Net Income -20.76M -15.22M -21.62M -30.7M
Change In Cash 19.58M -7.7M 69.11M -16.76M
Effect Of Exchange Rate 946k 946k 2.6M 244k
Total Cash From Operating Activities -18.29M -15.05M -20.57M -22.36M
Depreciation 725.13k 795k 810k 1.01M
Change To Account Receivables 1.57M -1.03M -4.03M 2M
Other Cashflows From Financing Activities -9.06M -865k -6.64M -99k
Change To Netincome 2.15M 2.4M 4.14M 7.34M
Capital Expenditures -32k -32k -32k -32k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 10.27M 9.4M 9.91M 15.28M
Income Before Tax -20.53M -15.07M -21.58M -30.59M
Net Income -20.76M -15.22M -21.62M -30.7M
Selling General Administrative 10.75M 7.9M 12.43M 17.97M
Gross Profit 823.78k 2.39M 3.47M 2.95M
Ebit -20.19M -14.9M -18.86M -30.29M
Operating Income -20.19M -14.9M -18.86M -30.29M
Interest Expense -1.09M -1.04M -543k -67k
Income Tax Expense 230.78k 147k 45k 105k
Total Revenue 2.6M 4.17M 7.3M 6.87M
Cost Of Revenue 1.78M 1.78M 3.83M 3.92M
Total Other Income ExpenseNet -342.52k -171k -2.71M -303k
Net Income From Continuing Ops -20.76M -15.22M -21.62M -30.7M
Net Income Applicable To Common Shares -20.76M -15.22M -21.62M -30.7M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 19.92M 15.69M 7.25M 6.16M
Total Stockholder Equity 26.63M 14.37M 97.35M 80.62M
Other Current Liabilities 2.63M 1.04M 1.11M 725k
Total Assets 46.55M 30.06M 104.6M 86.78M
Common Stock 120.93M 100.3M 211.53M 219.58M
Other Current Assets
Retained Earnings -111.03M -108.37M -129.99M -160.69M
Treasury Stock -28.7k 7.37M 4.57M 4.75M
Cash 30.69M 14.8M 83.91M 67.15M
Total Current Liabilities 7.88M 8.22M 4.81M 4.16M
Other Stockholder Equity -28.7k 7.37M 4.57M 4.75M
Property, Plant, and Equipment 1.21M 2.22M 2.28M 1.9M
Total Current Assets 37.92M 22.81M 97.74M 77.12M
Net Tangible Assets 19.2M 9.34M 92.77M 76.49M
Net Receivables 3.17M 3.31M 7.43M 1.41M
Accounts Payable 3.91M 3.03M 3.38M 3.18M


Insider Transactions

Here are the insider transactions of stock shares related to Profound Medical Corp:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Knudson (Ken)Acquisition or disposition in the public market at price 5.59 per share.D2022-09-07Senior Officer of Issuer5k
Knudson (Ken)Acquisition or disposition in the public market at price 6.99 per share.D2022-06-29Senior Officer of Issuer3k
Knudson (Ken)Acquisition or disposition in the public market at price 7.56 per share.D2022-06-14Senior Officer of Issuer2.5k
Rosenthal (Arthur Lee)Acquisition or disposition in the public market at price 9.48 per share.D2022-06-02Director of Issuer538
Rosenthal (Arthur Lee)Acquisition or disposition in the public market at price 8.93 per share.D2022-06-01Director of Issuer3k
Rosenthal (Arthur Lee)Acquisition or disposition in the public market at price 9.22 per share.D2022-06-01Director of Issuer500
Rosenthal (Arthur Lee)Acquisition or disposition in the public market at price 9.08 per share.D2022-05-31Director of Issuer6.76k
Menawat (Arun Swarup Ph.D.)Acquisition or disposition in the public market at price 6.55 per share.D2022-05-24Director of Issuer1k
Lavoie (Cynthia Ph.D.)Acquisition or disposition in the public market at price 6.76 per share.D2022-05-20Director of Issuer2.4k
Menawat (Arun Swarup Ph.D.)Acquisition or disposition in the public market at price 6.90 per share.D2022-05-20Director of Issuer2.5k
Lortie (Murielle CPA)Acquisition or disposition in the public market at price 6.71 per share.D2022-05-20Director of Issuer1.74k
Dewan (Rashed Osman)Acquisition or disposition in the public market at price 6.94 per share.D2022-05-18Senior Officer of Issuer4k
Lavoie (Cynthia Ph.D.)Acquisition or disposition in the public market at price 6.89 per share.D2022-05-13Director of Issuer600
Menawat (Arun Swarup Ph.D.)Acquisition or disposition in the public market at price 6.92 per share.D2022-05-13Director of Issuer30k
Knudson (Ken)Acquisition or disposition in the public market at price 7.07 per share.D2022-05-12Senior Officer of Issuer8k
Menawat (Arun Swarup Ph.D.)Acquisition or disposition in the public market at price 6.66 per share.D2022-05-12Director of Issuer30.52k
Ellacott Brian RAcquisition or disposition in the public market at price 7.05 per share.D2022-05-12Director of Issuer50k
Menawat (Arun Swarup Ph.D.)Acquisition or disposition in the public market at price 8.53 per share.D2022-03-09Director of Issuer15k
Knudson (Ken)Acquisition or disposition in the public market at price 8.34 per share.D2022-03-08Senior Officer of Issuer4.2k
Menawat (Arun Swarup Ph.D.)Acquisition or disposition in the public market at price 8.11 per share.D2022-03-08Director of Issuer45.58k
Knudson (Ken)D2021-12-30Senior Officer of Issuer

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Profound Medical Corp. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Profound Medical Corp

Here is the result of two systematic investment strategies applied to Profound Medical Corp. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Profound Medical Corp

The following chart shows the equity curve of the two systematic investment strategies applied to Profound Medical Corp:

Profound Medical Corp automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 62.23% on the backtest period.

Performance at glance

Performance

62.23 %

Latent gain

1235.48 $

Invested capital

1985.22 $

Annualized return

13.77 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Profound Medical Corp

This is the result of two momentum investment strategies applied to Profound Medical Corp. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Profound Medical Corp

The following chart shows all the entries opened by the momentum investment system on Profound Medical Corp:

Profound Medical Corp momentum entries
  • The first momentum investment strategy would give 2343.58% of return on Profound Medical Corp. That represents 128440.66$ of latent gain with 5480.54$ of employed capital.
  • The second momentum investment strategy would give 70.63% of return on Profound Medical Corp. That represents 2821.38$ of latent gain with 3994.52$ of employed capital.
Performance at glance (1Q Momentum)

Performance

2343.58 %

Latent gain

128440.66 $

Invested capital

5480.54 $

Annualized return

-8.73 %
Performance at glance (2Q Momentum)

Performance

70.63 %

Latent gain

2821.38 $

Invested capital

3994.52 $

Annualized return

17.48 %

Momentum equity curve on Profound Medical Corp

The following chart shows the equity curve of the two momentum strategies applied to Profound Medical Corp:

Profound Medical Corp momentum equity

Note: the dividends potentially given by Profound Medical Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Profound Medical Corp

The following chart shows the employed capital evolution of the two momentum strategies on Profound Medical Corp since the beginning:

Profound Medical Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Profound Medical Corp

Buy the dip entry openings on Profound Medical Corp

Profound Medical Corp

The performance achieved by the robo-advisor on Profound Medical Corp is -22.0%. That represents -274.58$ of latent gain with 1248.28$ of employed capital. The following chart shows Profound Medical Corp stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Profound Medical Corp, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-22.0 %

Latent gain

-274.58 $

Invested capital

1248.28 $

Annualized return

-8.73 %

Equity curve of the strategy applied to Profound Medical Corp

The following chart shows the result of the investment strategy applied to Profound Medical Corp:

Profound Medical Corp

Note: the dividends potentially given by Profound Medical Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Profound Medical Corp

The following chart shows the employed capital evolution since the beginning of the investment strategy on Profound Medical Corp:

Profound Medical Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Profound Medical Corp

In this section, I will compare the three previous investment strategies applied to Profound Medical Corp.

Equity curve comparison on Profound Medical Corp

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Profound Medical Corp investment strategy comparison

Employed capital comparison on Profound Medical Corp

Profound Medical Corp investment comparison

Performance comparison on Profound Medical Corp

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 62.23% 1235.48$ 1985.22$ 13.77%
Momentum 1 quarter 2343.58% 128440.66$ 5480.54$ 547.57%
Momentum 2 quarters 70.63% 2821.38$ 3994.52$ 17.48%
Non-directional -22.0% -274.58$ 1248.28$ -8.73%
Annualized return comparison

Automatic investment

13.77 %

Momentum 1Q

17.48 %

Momentum 2Q

17.48 %

Non-directional

-8.73 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Profound Medical Corp:

Positive correlations

Most correlated stocks this year

  • Profound Medical Corp

  • Most correlated stocks last 3 months

  • Profound Medical Corp
  • ZOO DIGITAL GROUP PLC ORD 1P

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • Brainsway Ltd

  • Note: The algorithm computes the probability of correlation between Profound Medical Corp and the other stocks. There may be false positives or some missing correlated stocks. If the price of Profound Medical Corp does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Profound Medical Corp
    Country Canada
    City Mississauga
    Address 2400 Skymark Avenue
    Phone
    Website www.profoundmedical.com
    FullTime employees 146
    Industry Medical Devices
    Sector Healthcare
    Exchange XNAS
    Ticker PROF
    Market www.nasdaq.com

    Profound Medical Corp ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown